Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




A Highly Conserved Region of Hepatitis C Virus RNA a Promising Drug Target

By LabMedica International staff writers
Posted on 25 Jun 2012
A genetically conserved region within the RNA of the Hepatitis C virus (HCV) is the focus of research designed to aid development of drugs that would kill all forms of this notoriously variable pathogen.

Investigators at the University of Warwick (United Kingdom) employed advanced genomic analysis techniques to study the RNA structure and long-range interactions of the SL9266 cis-acting replication element located within the HCV NS5B coding region.

They reported in the May 4, 2012, online edition of the journal Nucleic Acids Research that the SL9266 region is very highly conserved and present in all Hepatitis C viruses. More...
Thanks to its novel three-dimensional structure, this region may contribute a switch function that modulates the mutually incompatible translation and replication events that must occur for replication of the positive-strand RNA genome of HCV.

Senior author Dr. David Evans, professor of life sciences at the University of Warwick, said, “Hepatitis C is a growing concern worldwide and is set to place a massive demand on the organ transplant system. We are already at the stage in many countries where the main need for liver transplants is due to liver damage caused by the Hepatitis C virus. Current medication is not effective in all cases, and that is why it is vital that we continue to build on this early-stage research to focus drug development work on treatment which works across all Hepatitis C genotypes.”

Related Links:
University of Warwick



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.